UK Pharma Wins Tariff Exemption in US Trade Deal, Faces Broader Import Challenges Under Trump Agreements episode artwork

EPISODE · Dec 17, 2025 · 2 MIN

UK Pharma Wins Tariff Exemption in US Trade Deal, Faces Broader Import Challenges Under Trump Agreements

from United Kingdom Tariff News and Tracker · host Inception Point AI

Welcome to United Kingdom Tariff News and Tracker, your essential guide to the latest US trade developments affecting UK businesses under President Trump. In a major win for the UK life sciences sector, the US and UK have struck a landmark agreement in principle on pharmaceuticals and medtech, as detailed by Mills & Reeve and AFS Law. UK-origin medicines, pharmaceutical ingredients, and medical technology are now exempt from US tariffs for at least three years, shielding them from Section 232 duties. In exchange, the UK commits to boosting spending on innovative treatments by 25%, with NICE raising its cost-effectiveness threshold from £20,000-£30,000 to £25,000-£35,000 per QALY gained. This could greenlight 3-5 more new medicines annually. Plus, the Voluntary Scheme for Branded Medicines Pricing and Access payment rate drops to 14.5% in 2026 from 22.9% in 2025, easing pressures on pharma firms. Broader tariffs pose challenges, though. The Manufacturer reports the UK faces a general 10% US tariff on imports, part of Trump's sweeping hikes now averaging 17.9% per Yale's Budget Lab analysis cited by Freiheit.org. EY Tax News notes some tariffs start at zero percent on January 1, 2026, rising to 10% in 2027 and 15% in 2028. AFS Law highlights exemptions for UK pharma amid Section 301 extensions through November 2026, but UK exporters must navigate rising shipping and customs costs, as warned by Power Forwarding. A snag: Alliance News reports the US has suspended implementation of a UK tech cooperation deal on December 16, signaling tensions in other sectors. These moves stem from the May 2025 UK-US Economic Prosperity Deal, balancing tariff relief with pricing reforms. UK firms in pharma and medtech gain a lifeline, but manufacturers watch general rates warily amid Trump's reciprocal tariff push. Thanks for tuning in, listeners—subscribe now for weekly updates to stay ahead. This has been a Quiet Please production, for more check out quietplease.ai. For more check out https://www.quietperiodplease.com/ Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q This content was created in partnership and with the help of Artificial Intelligence AI.

Welcome to United Kingdom Tariff News and Tracker, your essential guide to the latest US trade developments affecting UK businesses under President Trump. In a major win for the UK life sciences sector, the US and UK have struck a landmark agreement in principle on pharmaceuticals and medtech, as detailed by Mills & Reeve and AFS Law. UK-origin medicines, pharmaceutical ingredients, and medical technology are now exempt from US tariffs for at least three years, shielding them from Section 232 duties. In exchange, the UK commits to boosting spending on innovative treatments by 25%, with NICE raising its cost-effectiveness threshold from £20,000-£30,000 to £25,000-£35,000 per QALY gained. This could greenlight 3-5 more new medicines annually. Plus, the Voluntary Scheme for Branded Medicines Pricing and Access payment rate drops to 14.5% in 2026 from 22.9% in 2025, easing pressures on pharma firms. Broader tariffs pose challenges, though. The Manufacturer reports the UK faces a general 10% US tariff on imports, part of Trump's sweeping hikes now averaging 17.9% per Yale's Budget Lab analysis cited by Freiheit.org. EY Tax News notes some tariffs start at zero percent on January 1, 2026, rising to 10% in 2027 and 15% in 2028. AFS Law highlights exemptions for UK pharma amid Section 301 extensions through November 2026, but UK exporters must navigate rising shipping and customs costs, as warned by Power Forwarding. A snag: Alliance News reports the US has suspended implementation of a UK tech cooperation deal on December 16, signaling tensions in other sectors. These moves stem from the May 2025 UK-US Economic Prosperity Deal, balancing tariff relief with pricing reforms. UK firms in pharma and medtech gain a lifeline, but manufacturers watch general rates warily amid Trump's reciprocal tariff push. Thanks for tuning in, listeners—subscribe now for weekly updates to stay ahead. This has been a Quiet Please production, for more check out quietplease.ai. For more check out https://www.quietperiodplease.com/ Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q This content was created in partnership and with the help of Artificial Intelligence AI.

NOW PLAYING

UK Pharma Wins Tariff Exemption in US Trade Deal, Faces Broader Import Challenges Under Trump Agreements

0:00 2:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

MG Show MG Show The MG Show, hosted by Jeffrey Pedersen and Shannon Townsend, is a leading alternative media platform dedicated to uncovering the truth behind today’s most pressing political issues. Launched in 2019, the show has grown exponentially, offering unfiltered insights, comprehensive research, and real-time analysis. With a commitment to independent journalism and factual integrity, the MG Show empowers its audience with knowledge and encourages active participation in the political discourse. Breaking News Show | eTurboNews Juergen Thomas Steinmetz News is relevant to the global travel and tourism industry, human rights and global issues.Breaking news when it happens and only from the source. Eat to Live Jenna Fuhrman, Dr. Fuhrman Our health is our most precious gift and smart nutrition can change your life. Each month, join Dr. Fuhrman and his daughter, Jenna Fuhrman as they discuss important topics in the world of nutrition. Eat to Live will change the way you eat and think about food. French Your Way Jessica: Native French teacher founder of French Your Way Boost your French listening skills and test your comprehension with this one of a kind series of podcasts. Get the chance to listen to a real conversation between native speakers talking at normal speed AND customise your learning experience through carefully designed sets of questions (2 levels of difficulty) available for download at www.frenchvoicespodcast.com. All interviews also come with the transcript. French teacher Jessica interviews native speakers of French from around the world who share a bit of their life and passion. Where else would you meet in one same place a French yoga teacher based in Melbourne, a soap manufacturer from Provence, or a couple cycling around the world?

Frequently Asked Questions

How long is this episode of United Kingdom Tariff News and Tracker?

This episode is 2 minutes long.

When was this United Kingdom Tariff News and Tracker episode published?

This episode was published on December 17, 2025.

What is this episode about?

Welcome to United Kingdom Tariff News and Tracker, your essential guide to the latest US trade developments affecting UK businesses under President Trump. In a major win for the UK life sciences sector, the US and UK have struck a landmark...

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this United Kingdom Tariff News and Tracker episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!